MagForce AG (MF6):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MagForce AG (MF6) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6617
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment. The company’s products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. Its NanoActivator creates a magnetic field that can be used to treat tumors in all areas of the body. MagForce’s NanoTherm is a liquid that reacts to the presence of magnetic field. The company’s NanoPlan uses the bioheat transfer equation to help the physician in charge estimate treatment temperatures and the magnetic field strength. Its products are used in the treatment of prostate cancer, pancreatic cancer, esophageal cancer and glioblastoma. The company operates through therapy centers located in Berlin, Munster, Kiel, Cologne and Frankfurt, Germany. MagForce is headquartered in Berlin, Germany.

MagForce AG (MF6) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MagForce AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MagForce AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MagForce AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MagForce AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MagForce AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MagForce AG, Medical Equipment, Deal Details 10
Venture Financing 10
MagForce USA Raises USD15 Million in Venture Financing 10
Equity Offering 11
MagForce USA Raises USD9 Million in Private Placement 11
Magforce Raises USD5.6 Million in Private Placement of Shares 12
Magforce Raises USD13 Million in Private Placement of Shares 13
MagForce Increases Size Of Rights Offering For US$44 Million 14
MagForce Completes Private Placement Of Shares For US$6 Million 15
MagForce AG – Key Competitors 16
MagForce AG – Key Employees 17
MagForce AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
May 03, 2018: MagForce Publishes Financial Results for the Year 2017 and Operative Highlights 19
Sep 29, 2017: MagForce Publishes Financial Results for the First Half of 2017 and Operative Highlights 22
Jun 30, 2017: MagForce Publishes Financial Results for the Year 2016 and Operative Highlights 25
Product News 28
Aug 10, 2017: MagForce announces positive results of 2017 Annual General Meeting 28
May 10, 2017: MagForce reports highlights of Symposium for Focal Therapy in Glioblastoma at WFNOS 2017 Meeting 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
MagForce AG, Medical Equipment, Key Facts, 2017 2
MagForce AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MagForce AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MagForce AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MagForce AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MagForce AG, Deals By Market, 2012 to YTD 2018 8
MagForce AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MagForce USA Raises USD15 Million in Venture Financing 10
MagForce USA Raises USD9 Million in Private Placement 11
Magforce Raises USD5.6 Million in Private Placement of Shares 12
Magforce Raises USD13 Million in Private Placement of Shares 13
MagForce Increases Size Of Rights Offering For US$44 Million 14
MagForce Completes Private Placement Of Shares For US$6 Million 15
MagForce AG, Key Competitors 16
MagForce AG, Key Employees 17
MagForce AG, Other Locations 18
MagForce AG, Subsidiaries 18

List of Figures
MagForce AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MagForce AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MagForce AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MagForce AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MagForce AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MagForce AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MagForce AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MagForce AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MagForce AG (MF6):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ITV plc:企業の戦略・SWOT・財務情報
    ITV plc - Strategy, SWOT and Corporate Finance Report Summary ITV plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • PTC India Ltd (PTC):企業の財務・戦略的SWOT分析
    PTC India Ltd (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Exiqon AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Exiqon AS (Exiqon), a subsidiary of Qiagen NV, is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company provides product categories such as microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reag …
  • Mount Tam Biotechnologies Inc (MNTM):製薬・医療:M&Aディール及び事業提携情報
    Summary Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that offers development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamycin analog …
  • BP Plc (BP.):企業の財務・戦略的SWOT分析
    BP Plc (BP.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Taageer Finance Co (TFCI):企業の財務・戦略的SWOT分析
    Taageer Finance Co (TFCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Celsia SA ESP (CELSIA):企業の財務・戦略的SWOT分析
    Summary Celsia SA ESP (Celsia), formerly Compania Colombiana de Inversiones SA ESP, a subsidiary of Grupo Argos SA, is an energy company that generates, transmits, distributes, and sells electricity. The company’s product categories include home line, solar energy, backup energy, thermal network, ef …
  • Verastem Inc (VSTM):医療機器:M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Stereotaxis Inc (STXS):医療機器:M&Aディール及び事業提携情報
    Summary Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatm …
  • Pacira Pharmaceuticals Inc (PCRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pacira Pharmaceuticals Inc (Pacira) discovers, develops, manufactures and commercializes drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic indicated for infiltra …
  • RS Software (India) Limited (RSSOFTWARE):企業の財務・戦略的SWOT分析
    RS Software (India) Limited (RSSOFTWARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Top Glove Corporation Berhad (TOPGLOV):医療機器:M&Aディール及び事業提携情報
    Summary Top Glove Corporation Berhad (Top Glove) is a manufacturer and distributor of rubber gloves. The company’s products include nitrile gloves, vinyl gloves, latex gloves, surgical gloves, clean room gloves, household gloves, polyisoprene gloves, and cast polyethylene gloves. It also provides th …
  • Lear Corporation:企業の戦略・SWOT・財務情報
    Lear Corporation - Strategy, SWOT and Corporate Finance Report Summary Lear Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Diagnostica Stago Inc:企業の製品パイプライン分析2018
    Summary Diagnostica Stago Inc (Stago), a subsidiary of Diagnostica Stago SAS, is a medical device company that develops and distributes in-vitro diagnostic products. The company develops coagulation automation systems. It provides products such as hemostasis analyzers, viscosity based detection syst …
  • YGM Trading Ltd.:企業の戦略・SWOT・財務情報
    YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Corus Entertainment Inc. (CJR.B):企業の財務・戦略的SWOT分析
    Corus Entertainment Inc. (CJR.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Galliford Try Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kohl’s Corp (KSS):企業の財務・戦略的SWOT分析
    Kohl's Corp (KSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • United Supermarkets LLC:戦略・SWOT・企業財務分析
    United Supermarkets LLC - Strategy, SWOT and Corporate Finance Report Summary United Supermarkets LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nutra Pharma Corp (NPHC):医療機器:M&Aディール及び事業提携情報
    Summary Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus (HIV), multiple sclerosis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆